State of Alaska Department of Revenue Sells 146 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Posted by Defense World Staff on Jun 30th, 2023

State of Alaska Department of Revenue lessened its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 0.6% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,242 shares of the biotechnology company’s stock after selling 146 shares during the period. State of Alaska Department of Revenue’s holdings in Axon Enterprise were worth $5,450,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of AXON. Valeo Financial Advisors LLC bought a new position in Axon Enterprise in the first quarter worth approximately $240,000. Naples Global Advisors LLC bought a new position in Axon Enterprise in the first quarter worth approximately $225,000. AE Wealth Management LLC raised its stake in Axon Enterprise by 3.9% in the first quarter. AE Wealth Management LLC now owns 1,418 shares of the biotechnology company’s stock worth $319,000 after buying an additional 53 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in Axon Enterprise by 21.9% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 58,376 shares of the biotechnology company’s stock worth $13,126,000 after buying an additional 10,498 shares in the last quarter. Finally, Raymond James & Associates raised its stake in Axon Enterprise by 21.3% in the first quarter. Raymond James & Associates now owns 104,005 shares of the biotechnology company’s stock worth $23,386,000 after buying an additional 18,249 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 2,600 shares of the company’s stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $224.36, for a total value of $583,336.00. Following the sale, the chief executive officer now directly owns 2,985,660 shares of the company’s stock, valued at $669,862,677.60. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Axon Enterprise news, CEO Patrick W. Smith sold 2,600 shares of the company’s stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $224.36, for a total value of $583,336.00. Following the sale, the chief executive officer now directly owns 2,985,660 shares of the company’s stock, valued at $669,862,677.60. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Hadi Partovi bought 10,000 shares of the company’s stock in a transaction dated Thursday, May 25th. The shares were acquired at an average price of $190.75 per share, for a total transaction of $1,907,500.00. Following the completion of the transaction, the director now directly owns 388,817 shares in the company, valued at $74,166,842.75. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 45,250 shares of company stock valued at $8,735,200 and have sold 7,275 shares valued at $1,504,121. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

Shares of AXON opened at $195.83 on Friday. The firm has a market capitalization of $14.47 billion, a PE ratio of 103.61 and a beta of 0.92. The company has a debt-to-equity ratio of 0.48, a current ratio of 3.33 and a quick ratio of 2.97. Axon Enterprise, Inc. has a 1-year low of $88.61 and a 1-year high of $229.95. The company’s fifty day moving average price is $198.55 and its 200-day moving average price is $202.18.

Axon Enterprise (NASDAQ:AXON – Free Report) last announced its quarterly earnings data on Tuesday, May 9th. The biotechnology company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.48. Axon Enterprise had a net margin of 10.76% and a return on equity of 10.65%. The firm had revenue of $343.04 million for the quarter, compared to analyst estimates of $312.07 million. On average, equities research analysts predict that Axon Enterprise, Inc. will post 1.59 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have issued reports on AXON. JPMorgan Chase & Co. raised shares of Axon Enterprise from a “neutral” rating to an “overweight” rating and set a $236.00 price target on the stock in a report on Thursday, May 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $240.00 price target on shares of Axon Enterprise in a report on Thursday, April 13th. TheStreet lowered shares of Axon Enterprise from a “b-” rating to a “c+” rating in a report on Friday, May 26th. StockNews.com began coverage on shares of Axon Enterprise in a report on Thursday, May 18th. They issued a “hold” rating on the stock. Finally, The Goldman Sachs Group began coverage on shares of Axon Enterprise in a report on Tuesday, March 7th. They issued a “buy” rating and a $263.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $232.64.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.